BrightSpring Health Services Inc (BTSG) has seen its stock price exceed the average analyst 12-month target of $19.18, currently trading at $19.57 per share. This significant movement invites analysts to either downgrade on valuation or revise their target expectations upward based on the company’s fundamental developments.
Within the Zacks coverage universe, there are 11 analysts offering differing opinions on BTSG, with targets ranging from a low of $13.00 to a high of $22.00, resulting in a standard deviation of $2.75. Currently, 9 analysts rate the stock as a strong buy, while 1 rates it as a buy, and 1 holds it, reflecting a favorable outlook overall.
The average rating for BTSG is 1.23 on a scale where 1 represents a strong buy and 5 indicates a strong sell. The trend shows a slight decline from the previous month’s average rating of 1.05, indicating ongoing investor confidence in the health services company.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
